Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the...

Related Keywords

United States ,Johnc Jacobs ,Ali Chartan ,Erika Schultz ,European Medicines Agency ,Nasdaq ,Serum Institute Of Indiapvt ,Novavax Inc ,Us Centers For Disease ,Rite Aid ,World Health Organization ,Linkedin ,Centers For Disease ,Vaccine Administration Errors ,Prnewswire Novavax Inc ,Drug Administration ,Exchange Commission ,Emergency Use Authorization ,Disease Control ,Biologics Evaluation ,Chief Executive Officer ,Coronavirus Disease ,Fact Sheet ,Vaccine Adverse Event Reporting System ,Fax Number ,Telephone Number ,Adverse Events ,Vaccine Administration ,Serum Institute ,Financial Condition ,Annual Report ,Quarterly Reports ,Medicines Agency ,Health Organization ,Novavax ,Nc ,